Stock screenerAll disclosures → EDGAR →
BIAF
Conviction 76HealthcareScan · Tue, Sep 8, 2026Bearish belt hold
BIAF$8.90-41.72%
ResistanceSupportVol 14Vol MA14 10.23M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
bioAffinity Technologies, Inc.SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.bioaffinitytech.com ↗
Price8.90
Change-41.72%
Gap-30.45%
Rel volume0.15×
Avg volume15.77M
Avg $ vol70.77M
SMA 204.38
SMA 502.17
SMA 2001.87
Price vs 50+310.82%
Price vs 200+377.21%
MA stackbullish
50/200 crossgolden · 1d
Supertrendup · 8.53
RSI (14)62
MACD hist0.93
MACD cross—
Stoch %K / %D43 / 70
ADX (14)63
+DI / −DI52 / 11
RSI divergence—
MACD divergence—
ATR %+24.43%
ADR %18.63%
52w high15.27
52w low0.1691
From 52w high-41.72%
Above 52w low+5163.16%
New 52w highNo
SqueezeOff
Bollinger width401.85%
%B0.76
Donchian pos42.82%
Donchian high20.35
Donchian low0.3252
AVWAP (52w high)14.87
vs AVWAP high-40.13%
AVWAP (52w low)3.49
vs AVWAP low+155.16%
OBV trendUp
Chaikin MF (20)-0.31
Today vs 20d0.15×
Avg vol (14d)10.23M
Avg vol (20d)15.77M
Avg $ vol (20d)70.77M
Market cap72.11M
RS 3m (vs SPY)+778.23%
RS 6m (vs SPY)+1353.72%
RS line new highYes
Trend template7/8
Technical rank94.0
1 week+95.18%
1 month+1645.10%
3 months+456.25%
6 months+739.62%
1 year+3623.85%
YTD+629.51%
P/E-4.84
P/B19.13
P/S11.70
P/FCF-7.68
EPS-8.66
Div yield—
ROE-395.61%
ROA-195.68%
Debt/Eq0.03
Current1.44
EV/EBITDA—
Gross margin0.07%
Net margin-241.96%
Rev growth-34.18%
EPS growth-64.93%
Price target—
Target upside—
Analyst rating—
Institutional8.94%
Ent. value69.8M
Revenue1.51M
Net income-3.37M
Gross profit223.78K
Free cash flow-9.39M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out4.53M
Employees57
ListedThu, Sep 1, 2022
Free float4.37M
Float %97.0%
Short interest195.69K
Days to cover0.5d
Short volume60.7%
Squeeze score25 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction76 / 100
Pattern quality—
Tech rank94.0 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish belt hold
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Post-Market Losers: Notable After-Hours DeclinersChartMill · Tue, Sep 8, 2026
- There are notable gap-ups and gap-downs in today's session.ChartMill · Tue, Sep 8, 2026
- Morning Market Movers: FCUV, BNC, BIAF, DYN See Big SwingsRTTNews · Tue, Sep 8, 2026
- (BIAF) Volatility Zones as Tactical TriggersStock Traders Daily · Tue, Sep 8, 2026
- Curious about the stocks that are showing activity after the closing bell on Monday?ChartMill · Mon, Sep 7, 2026
- BIAF Stock Slides As bioAffinity’s Dilution And Reverse Split Reshape Trading Setupstockstotrade.com · Sat, Sep 5, 2026
- bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?Yahoo Finance · Sat, Sep 5, 2026
- AOUT, NX, and BIAF stocks soar on strong earnin...Pluang · Fri, Sep 4, 2026
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · Fri, Sep 4, 2026
- symbol__ Stock Quote Price and ForecastCNN · Fri, Sep 4, 2026
Congress activity
Disclosed STOCK Act trades in BIAF
No recent disclosed trades by Congress in BIAF. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BIAF
No recent insider (Form 4) filings in BIAF. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in BIAF · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.